Best ASX Stocks Under $1 to Buy

For investors hunting quality stocks below a dollar, these ASX stocks are proof that price isn’t always the measure of potential as each of them are backed by impressive cash flow and growth catalysts.

Best ASX Stocks Under $1

Infini Resources Limited (ASX: I88)

Reckon Limited (ASX: RKN)

Austco Healthcare Limited (ASX: AHC)

Fenix Resources Limited (ASX: FEX)

Infini Resources Limited (ASX: I88)

made good progress this month at its Portland Creek Uranium Project in Newfoundland, Canada. 

The company increased its land size by 68% to more than 25,000 hectares, giving it better control over important mineralised areas.

Infini recorded a FY25 net loss of about $2.78 million due to its continued spending on exploration. It ended the year with cash of $0.62 million though it later raised $3.04 million.

The company also secured CAD$150,000 from the government. With uranium and other key minerals becoming more important for clean energy, Infini’s larger land area and strong drill results put it in a good position for further growth through 2026.

Reckon Limited (ASX: RKN)

has been doing pretty well as a software company providing SaaS services. 
In the first half of FY2025, the company made around $33 million in revenue, which is 16% higher than last year. EBITDA also went up 21 to $14 million and NPAT increased 35% to $4 million. 

The Legal Group part of the business grew its subscription revenue by 18% and the Reckon One cloud platform jumped 26% helped by the Cashflow Manager buyout which added 20,000 small business clients.
 The company distributed a fully franked dividend of 2.5 cents per share and has a strong balance sheet with only $4.8 million in net debt.

Around 94% of the total income now comes from cloud revenue. With SaaS adoption among small businesses and law firms and an improving earnings trend, Reckon looks like a solid company that gives both income and growth for long term investors.

Austco Healthcare Limited (ASX: AHC)

has been showing strong growth both operationally and financially.
For FY25, its revenue jumped 40% to $81.4 million while EBITDA rose 62% to $13 million, lifting margins to 16% and NPAT was almost $6 million. The company has no debt and holds $14.5 million in cash and had $13.4 million operating cash flow showing good cash conversion. 

It recently secured big contracts including a $3.4 million rollout for Mexico’s Angeles Health System and a $1 million software deal with West Park Hospital in Canada bringing total unfilled contracted revenue to $53.8 million. 

The acquisitions of Amentco and G&S Technologies helped expand its direct sales and service reach in Australia and New Zealand. With growing demand from ageing populations and more digitalisation in healthcare, Austco’s focus on recurring revenue and international growth points to a strong FY26 with better earnings and margins.

Fenix Resources Limited (ASX: FEX)

has kept showing solid performance as they shipped a record 2.4Mt of ore, which is 64% higher than last year.

It moved from being a single mine operator to a multi-mine producer with total capacity of 4Mtpa after starting the Shine and Beebyn-W11 mines.

FY25 EBITDA was $54.3 million and operating cash flow reached $71.9 million, ending the year with $56.8 million cash in hand showing strong control over finances. NPAT was $5.4 million because of lower iron ore prices but the company still declared a fully franked 1 cps dividend showing trust in its future cash flows.
Fenix also made strategic moves by taking a stake in Athena Resources and signing an MOU for the Mid-West Green Iron Project which aims at low emission steel production.

For FY26 it expects production between 4.0–4.4Mt at C1 costs of $70–80/wmt. With integrated logistics and growing port capacity, the company is entering the new year with strong scalability, good profits and more growth ahead.

(Source: Company Announcement)